Health Claim Disclaimers Consumer Perception Research Suggested To FDA
This article was originally published in The Tan Sheet
Executive Summary
The need for clear, easily understandable disclaimers on dietary supplements making health claims that do not meet the significant scientific agreement standard was stressed to FDA by numerous speakers at the agency's April 4 public meeting on the Pearson v. Shalala decision.
You may also be interested in...
Labeling Based On Consumer Comprehension Data Stressed By McClellan
Empirical data on consumer comprehension of food and drug labeling would play a prominent role in FDA rulemaking if the Senate confirms White House economic advisor Mark McClellan, MD/PhD, as the agency's new commissioner
Labeling Based On Consumer Comprehension Data Stressed By McClellan
Empirical data on consumer comprehension of food and drug labeling would play a prominent role in FDA rulemaking if the Senate confirms White House economic advisor Mark McClellan, MD/PhD, as the agency's new commissioner
Labeling Based On Consumer Comprehension Data Stressed By McClellan
Empirical data on consumer comprehension of food and drug labeling would play a prominent role in FDA rulemaking if the Senate confirms White House economic advisor Mark McClellan, MD/PhD, as the agency's new commissioner